Key facts
- Chirpy’s last known valuation is $1.9M (Oct 2025).
- It has raised $330K; the latest was Seed Round ($330K) in Oct 2025.
- Notable investors include Deuce Capital, Lavender Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Chirpy
- ·The full record, as it builds
Funding rounds
No funding rounds for Chirpy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chirpy
Manufacturer of youth-focused nutritional and emotional well-being products designed to support natural mood, focus, sleep, and calm in children and teenagers. The company's platform combines pharmacist-formulated, science-backed supplements with natural ingredients and no added sugar, age-specific formulations for neurodivergent and neurotypical young people, and lifestyle education on "Good Mood Day" habits, enabling parents and caregivers to strengthen mental health foundations and everyday emotional resilience in young minds.
- Sector
- Consumer Products and Services (B2C)
- HQ
- St Albans, United Kingdom
- Founded
- 2025
- Employees
- 3
- Website
- wearechirpy.com/
- Ownership
- Privately Held (backing)
Chirpy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chirpy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chirpy in its N-PORT filings yet. We sweep new filings monthly.